AIM IMMUNOTECH INC. Proceeds from Sale of Buildings
AIM IMMUNOTECH INC. (AIM) reported Proceeds from Sale of Buildings of $1.05 million for the 12-month period ending 2018-12-31, per its 10-K filed 2020-03-30.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromSaleOfBuildings · last filed 2023-03-31
- AIM IMMUNOTECH INC. proceeds from sale of buildings for the quarter ending 2018-12-31 was $0.00.
- AIM IMMUNOTECH INC. proceeds from sale of buildings for the quarter ending 2018-09-30 was $0.00.
- AIM IMMUNOTECH INC. proceeds from sale of buildings for the quarter ending 2018-06-30 was $0.00.
- AIM IMMUNOTECH INC. proceeds from sale of buildings for the quarter ending 2018-03-31 was $1.05M.
- AIM IMMUNOTECH INC. proceeds from sale of buildings for fiscal 2018 was $1.05M.
| Period end | Proceeds from Sale of Buildings 0 month | Proceeds from Sale of Buildings 3 month | Proceeds from Sale of Buildings 6 month | Proceeds from Sale of Buildings 9 month | Proceeds from Sale of Buildings 12 month |
|---|---|---|---|---|---|
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $0.00 derived: sum of 2 quarters · filed 2020-03-30 | $0.00 derived: sum of 3 quarters · filed 2020-03-30 | $1.05M 10-K · filed 2020-03-30 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $0.00 derived: sum of 2 quarters · filed 2019-11-14 | $1.05M 10-Q · filed 2019-11-14 | ||
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $1.05M 10-Q · filed 2019-08-14 | |||
| 2018-03-31 | $1.05M 10-Q · filed 2019-05-15 | ||||
| 2018-03-16 | $4.08M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |